SCHEMBL9320154

SCHEMBL9320154

Clc1ccc(CCCCN2CCNCC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.63
DRD2 P14416 5/20 0.57
TMEM97 Q5BJF2 4/20 0.57
HTR1A P08908 4/20 0.57
HTR2A P28223 4/20 0.57
DRD3 P35462 4/20 0.57
DRD1 P21728 2/20 0.57
DRD5 P21918 2/20 0.57
HRH1 P35367 5/20 0.54
SLC6A2 P23975 3/20 0.54
HRH3 Q9Y5N1 3/20 0.54
SLC6A4 P31645 2/20 0.54
KCNH2 Q12809 2/20 0.54
CHRM2 P08172 1/20 0.54
ADRA2C P18825 1/20 0.54
SLC6A3 Q01959 1/20 0.54
CACNA1C Q13936 1/20 0.54
SCN5A Q14524 1/20 0.54
LMNA P02545 1/20 0.53
HTR2C P28335 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9319743 0.95 SIGMAR1 (0.70) SIGMAR1DRD2TMEM97HTR1AHTR2A
SCHEMBL10504465 0.89 SIGMAR1 (0.62) SIGMAR1DRD2TMEM97HTR1AHTR2A
SCHEMBL3500303 0.88 SIGMAR1 (0.68) SIGMAR1SLC6A2HRH3SLC6A4KCNH2
Hydrochloric Acid SCHEMBL14486498 0.86 SIGMAR1 (0.66) SIGMAR1TMEM97HRH1SLC6A2HRH3
Hydrochloric Acid SCHEMBL10503957 0.84 SIGMAR1 (0.66) SIGMAR1DRD2TMEM97HTR1AHTR2A
SCHEMBL10507686 0.83 SIGMAR1 (0.63) SIGMAR1DRD2TMEM97HTR1AHTR2A
SCHEMBL3251614 0.83 SIGMAR1 (0.90) SIGMAR1CCR3CYP1A2CYP2D6
SCHEMBL22561783 0.83 HRH3 (0.74) SIGMAR1DRD2TMEM97HTR1AHTR2A
SCHEMBL10502864 0.80 SIGMAR1 (0.66) SIGMAR1DRD2TMEM97HTR1AHTR2A
SCHEMBL2256688 0.80 SIGMAR1 (0.59) SIGMAR1DRD2SLC6A2HRH3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5286728-A Amino-substituted piperazine derivatives CIBA-GEIGY CORPORATION (US) 1994-02-15 US disclosed
EP-0524146-A1 Aminosubstituted Piperazinederivatives CIBA-GEIGY AG (CH) 1993-01-20 EP disclosed
EP-0122488-B1 BIS-(PIPERAZINYL- OR HOMOPIPERAZINYL)-ALKANES Boehringer Ingelheim Pharmaceuticals Inc. (US) 1989-06-07 EP disclosed
US-4725597-A ANTIALLERGEN, ANTIINFLAMMATORY AGENTS BOEHRINGER INGELHEIM LTD. (US) 1988-02-16 US disclosed
US-4722926-A Substituted phenylalkyl-(piperazinyl or homopiperazinyl)alkyl thiols and thiocarbamates useful for the treatment of immunological, inflammatory, and allergic disorders BOEHRINGER INGELHEIM LIMITED (US) 1988-02-02 US disclosed
EP-0127182-B1 1-PHENYLALKYL-4-(MERCAPTO AND CARBAMYLTHIO)ALKYL-PIPERAZINES AND -HOMOPIPERAZINES AND THEIR USE IN THE TREATMENT OF ALLERGIC DISEASES Boehringer Ingelheim Pharmaceuticals Inc. (US) 1986-12-30 EP disclosed
US-4618677-A Substituted phenylalkyl-(piperazinyl or homopiperazinyl)alkyl-thiols and -thiocarbamates useful for the treatment of immunological, inflammatory, and allergic disorders BOEHRINGER INGELHEIM LIMITED (US) 1986-10-21 US disclosed
EP-0127182-A1 1-Phenylalkyl-4-(mercapto and carbamylthio)alkyl-piperazines and -homopiperazines and their use in the treatment of allergic diseases Boehringer Ingelheim Pharmaceuticals Inc. (US) 1984-12-05 EP disclosed
EP-0122488-A1 Bis-(piperazinyl- or homopiperazinyl)-alkanes Boehringer Ingelheim Pharmaceuticals Inc. (US) 1984-10-24 EP disclosed